Eversept Partners »

Taysha Gene Therapies shares owned by Eversept Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Eversept Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.4M 1.7M 3.16

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
Inspire Med Sys (INSP)
Syndax Pharmaceuticals (SNDX)
Hca Holdings (HCA)
Bio-techne Corporation (TECH)
Danaher Corporation (DHR)
Healthequity (HQY)
Horizon Therapeutics Pub L SHS
Illumina (ILMN)
Community Health Systems (CYH)

View all positions for Eversept Partners

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
BlackRock
Citadel Advisors
Damian Sousa
Cowen And Company
Susquehanna International
T. Rowe Price Associates
Schonfeld Strategic Advisors

View all funds holding Taysha Gene Therapies